Scotland’s flagship life sciences project, Edinburgh BioQuarter, has been awarded £12 million by the development agency Scottish Enterprise and Edinburgh University to set up a technology commercialisation fund.

ACES winner Kee Square was spun out of the Politecnico di Milano with commercial ambitions for software that can help security services find their suspect.

The prospect of a sub-$1,000 human genome sequence moved closer as Oxford Nanopore Technologies Ltd agreed a marketing deal with Illumina Inc for its low-cost sequencing technology.

The Wellcome Trust is reaching outside the UK to fund translational research and derisk projects for future investors.